Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9
Closed 331
2022
Q3
$0 Buy
9
+8
+800% +$260 ﹤0.01% 1044
2022
Q2
$0 Hold
1
﹤0.01% 1044
2022
Q1
$0 Hold
1
﹤0.01% 993
2021
Q4
$0 Hold
1
﹤0.01% 980
2021
Q3
$0 Buy
+1
New +$40 ﹤0.01% 971
2019
Q4
Sell
-23
Closed -$1K 828
2019
Q3
$1K Hold
23
﹤0.01% 735
2019
Q2
$1K Hold
23
﹤0.01% 712
2019
Q1
$0 Buy
+23
New +$403 ﹤0.01% 807
2018
Q1
Sell
-59
Closed -$5K 935
2017
Q4
$5K Hold
59
﹤0.01% 548
2017
Q3
$5K Buy
+59
New +$4.18K ﹤0.01% 565

Other funds holding ADNT

Howe & Rusling's ADNT Position: Q4 2022 in Review

Howe & Rusling sold out of Adient (ADNT) in Q4 2022, closing a stake of 9 shares.

Howe & Rusling first reported a position in ADNT in Q3 2017 and held it in 10 quarters. The position peaked at $5K in Q4 2017. 273 funds tracked by Wall St. Rank hold ADNT as of Q4 2022.

  • Howe & Rusling reported no remaining Adient position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 9 Adient shares in Q4 2022.
  • Howe & Rusling first reported a position in Adient in Q3 2017 and held it in 10 quarters.
  • Howe & Rusling's Adient position peaked at $5K in Q4 2017.
  • 273 funds tracked by Wall St. Rank held Adient as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.